Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

Facial Expression Awareness Training to Understand and Recognize Emotions

for
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 6 - 13

Code: NCT07923370

Recruiting
New

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07737314

Recruiting
New

Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Gynecologic Cancer Surgery

for
Prehabilitation, Preoperative Aerobic Training,
Location: Kingston
Sponsor: Jordan Leitch

Sex: Female

Age: 18+

Code: NCT07609082

Recruiting
New

SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET

for
Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer,
Location: Minneapolis MN
Sponsor: Full-Life Technologies UK Limited

Sex: All

Age: 18+

Code: NCT07873450

Phase 1, Phase 2, Recruiting
New

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

for
Advanced Solid Tumors, Recurrent or Progressive Glioblastoma,
Location: Fairfax VA, Tampa FL, Houston TX, Duarte CA
Sponsor: Crossbow Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07779798

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

for
Brain Metastases, Cancer (With CNS Involvement)
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT07227610

Phase 2, Recruiting

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

for
Rectal Cancer Stage II, Rectal Cancer Stage III,
Location: Anchorage AK
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 21+

Code: NCT06802172

Recruiting

DOAC - Dosing Options in AntiCoagulation Prophylaxis

for
Cancer, VTE (Venous Thromboembolism)
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT07005024

Phase 3, Recruiting

Decoupling Immunotherapy Toxicity and Cancer Response

for
Tumor, Cardiovascular
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07382752

Recruiting

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

for
SMARCB1-Deficient Malignancies, Epithelioid Sarcoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT06444880

Phase 2, Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Philadelphia PA, Columbus OH,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase 1, Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Washington D.C. DC, Durham NC,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06635785

Phase 1, Phase 2, Recruiting

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

for
Heart Failure, Cardiotoxicity, Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18 - 45

Code: NCT05023785

Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for
Solid Tumors
Location: New Haven CT, Hackensack NJ, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05471856

Phase 1, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Miami FL, Pittsburgh PA, Houston TX, Dallas TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

The STOP-MED CTRCD Trial

for
Heart Failure, Cardiotoxicity, Cardiac Toxicity,
Location: Boston MA, Ottawa, Toronto, Winnipeg, Edmonton
Sponsor: Dinesh Thavendiranathan

Sex: All

Age: 18+

Code: NCT06183437

Recruiting

64Cu-GRIP B in Patients With Advanced Malignancies

for
Prostate Cancer, Renal Cancer, Urethral Cancer,
Location: San Francisco CA
Sponsor: Rahul Aggarwal

Sex: All

Age: 18+

Code: NCT05888532

Phase 1, Phase 2, Recruiting

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

for
Cancer, Fertility Preservation
Location: San Diego CA, La Jolla CA, Duarte CA
Sponsor: University of California, San Diego

Sex: All

Age: 0 - 50

Code: NCT05443737

Phase 3, Recruiting

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

for
Venous Thromboembolism, Cancer,
Location: Ottawa, Sault Ste. Marie
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06603870

Recruiting

Intraoperative Tumor Margin Identification With ICG Dye Imaging

for
Benign Neoplasm, Malignant Neoplasm
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04752137

Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial